Reistone Biopharma | Press Release

Press Release

Reistone Biopharma Appoints Dr. Qais Mekki as Senior Vice President, Head of International Development, US Site Head

Shanghai, China/ Chicago, US/July 13, 2020/Reistone Biopharma Company Limited (Reistone Biopharma) recently announced the appointment of Dr. Qais Mekki as Senior Vice President, Head of International Development, US Site Head. He will be based in Chicago

2020-07-17 Learn more
R&D investment exceeds RMB 100 million! A approved clinical trial of the new drug intended to be used in the treatment of alopecia areata by Reistone Biopharma

Hengrui Medicine (600276) announced in the evening that Reistone Biopharma Company Limited, a subsidiary of the company, recently received the Notice of Clinical Trial approved and issued by NMPA.

2020-02-21 Learn more
Chasing Dreams in Medicine Valley | Min Wang Irwin of Reistone Biopharma: China's power to explore the global autoimmune diseases

Reistone, led by Min Wang Irwin, has been a new force to Zhangjiang Biopharma Base in recent years.

2019-08-17 Learn more